Author Question: When an organization invests in carefully designing assets for reuse, choosing assets for domain or ... (Read 57 times)

V@ndy87

  • Hero Member
  • *****
  • Posts: 571
When an organization invests in carefully designing assets for reuse, choosing assets for domain or product line, they are said to be engaged in:
 
  A) ad hoc reuse.
  B) facilitated reuse.
  C) designed reuse.
  D) managed reuse.
  E) ex ante reuse.

Question 2

In which SDLC phase is the information system coded, tested, and installed in the organization?
 
  A) Systems planning and selection
  B) Systems replacement
  C) Systems analysis
  D) Systems design
  E) Systems implementation and operation



izzat

  • Sr. Member
  • ****
  • Posts: 328
Answer to Question 1

C
Explanation: C) The focus of designed reuse is more on developing reusable assets than on finding existing assets that might be candidates for reuse.

Answer to Question 2

E
Explanation: E) During the implementation and operation phase all parts of the system are put into place and tested.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Eating food that has been cooked with poppy seeds may cause you to fail a drug screening test, because the seeds contain enough opiate alkaloids to register as a positive.

Did you know?

There are major differences in the metabolism of morphine and the illegal drug heroin. Morphine mostly produces its CNS effects through m-receptors, and at k- and d-receptors. Heroin has a slight affinity for opiate receptors. Most of its actions are due to metabolism to active metabolites (6-acetylmorphine, morphine, and morphine-6-glucuronide).

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

Asthma occurs in one in 11 children and in one in 12 adults. African Americans and Latinos have a higher risk for developing asthma than other groups.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

For a complete list of videos, visit our video library